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Abstract
Background: Sphingomyelin synthase 2 (SMS2) contributes to de novo sphingomyelin (SM) biosynthesis. Its
activity is related to SM levels in the plasma and the cell membrane. In this study, we investigated the possibility of
a direct relationship between SMS and atherosclerosis.
Methods: The Adenovirus containing SMS2 gene was given into 10-week ApoE KO C57BL/6J mice by femoral
intravenous injection. In the control group, the Adenovirus containing GFP was given. To confirm this model, we
took both mRNA level examination (RT-PCR) and protein level examination (SMS activity assay).
Result: We generated recombinant adenovirus vectors containing either human SMS2 cDNA (AdV-SMS2) or GFP
cDNA (AdV-GFP). On day six after intravenous infusion of 2 × 10
11 particle numbers into ten-week-old apoE KO mice,
AdV-SMS2 treatment significantly increased liver SMS2 mRNA levels and SMS activity (by 2.7-fold, 2.3-fold, p < 0.001,
respectively), compared to AdV-GFP treated mice. Moreover, plasma total cholesterol (TC), low-density lipoprotein
cholesterol (LDL-C), triglyceride (TG), and sphingomyelin (SM) levels were significantly increased by 39% (p < 0.05),
42% (p < 0.05), 68% (p < 0.001), and 45% (p < 0.05), respectively. Plasma high-density lipoprotein cholesterol (HDL-C),
phosphatidylcholine (PC), and PC/SM ratio were decreased by 42% (p < 0.05), 18% (p < 0.05), and 45% (p < 0.05),
respectively. On day 30, the atherosclerotic lesions on the aortic arch of AdV-SMS2 treated mice were increased, and
the lesion areas on the whole aorta and in the aortic root were significantly increased (p < 0.001). Furthermore, the
collagen content in the aorta root was significantly decreased (p < 0.01).
Conclusions: Our results present direct morphological evidence for the pro-atherogenic capabilities of SMS2. SMS2
could be a potential target for treating atherosclerosis.
Introduction
Sphingolipids are involved in many important biological
functions, including cell membrane formation, signal
transduction, and lipid metabolism, which are related to
the development of atherosclerosis [1]. Sphingomyelin
(SM) is one of the major phospholipids. Plasma mem-
brane SM and the ratio of SM/PC are independent risk
factors for coronary heart disease [2]; furthermore, these
lipids accumulate in atheromas both in humans and ani-
mal models [3]. Previous studies have shown that LDL
extracted from human atherosclerotic lesions is rich in
SM [4] and that plasma SM levels in apoE KO mice are
four-fold higher than those in wild-type mice [5], which
may partly explain the increase in atherosclerosis in
these mice. SM levels were increased five-fold in VLDL
from hypercholesterolemic rabbits [6]. As an inhibitor of
SPT (the first key enzyme in the SM biosynthetic path-
way), myriocin administration dramatically decreased
plasma SM levels and atherosclerotic lesions in apoE
KO mice [1,7]. These data suggest that elevated plasma
SM levels could promote atherogenesis. Sphingomyelin
synthase (SMS) is the last enzyme in SM biosynthesis
and has two isoforms, SMS1 and SMS2. Previous work
in our lab has shown that overexpression of SMS1 and
SMS2 increases lipoprotein atherogenic potential in
mice [8] and promotes cell apoptosis [9]. Atherogenesis
is initiated by the interaction of atherogenic lipoproteins
with the arterial wall [10]. Many processes have been
implicated in early atherogenesis. Among them, lipopro-
tein retention and aggregation are key steps [11,12]. In
this study, we evaluated the role of SMS2 overexpres-
sion in atherogenesis. Our results provide the first direct * Correspondence: mpwu@shmu.edu.cn
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motes atherosclerosis in mice.
Methods
Mice and diets
ApoE KO mice with a C57BL/6J background were pur-
chased from Peking University. They were divided into
four groups: groups 1 and 2: AdV-SMS2 treated and
groups 3 and 4: AdV-GFP treated. An appropriate aliquot
of purified recombinant AdV-SMS2 or AdV-GFP (2 ×
10
11 particle numbers) was infused into the femoral vein
of 10-week-old apoE KO mice on day 0 of the study.
These animals were fed a western-type diet (0.15% choles-
terol, 20% saturated fat). Six days later, groups 1 and 3
were sacrificed, and liver and blood samples were col-
lected. On day 30, groups 2 and 4 were sacrificed, and the
aorta arch, aorta root, and whole aorta were isolated for
analysis.
Recombinant adenovirus generation
A pShuttle-AdEasy system was used to create adeno-
virus vectors (Stratagene). We generated pShuttle-CMV-
SMS2 by inserting full-length SMS2 cDNAs into the
SalI/NotI and NotI/EcoRV sites of pShuttle-CMV. Then,
pShuttle-CMV-SMS2 was linearized by PmeI digestion
and recombined with pAdEasy-1 in BJ5183 cells. Correct
recombinants were selected and retransformed into
Escherichia coli (DH-5a). Purified recombinant plasmids
were linearized by PacI digestion and transfected into
HEK-293 cells to create adenoviruses. Recombinant
viruses were propagated in HEK-293 cells, purified, and
titered by standard methods, as described elsewhere [8].
The corresponding viruses were named AdV-SMS2. The
E1 genes (nucleotides 342-3,534) and the E3 genes
(nucleotides 28,138-30,818) were deleted in those virus
vectors. Recombinant adenovirus containing the GFP
gene (i.e., AdV-GFP) was purchased from Viraquest Inc.
SMS2 mRNA and activity assay
Total RNA was isolated from livers with Trizol (Invitro-
gen). SMS2 mRNA levels were measured by RT-PCR.
Briefly, 10 μg of total RNA was reverse-transcribed with
random primers and murine leukemia virus reverse
transcriptase (30°C for 10 min followed by 42°C for 120
min). They were amplified by PCR with 50 nM of pri-
mers using the following cycling program: initial step of
94°C for 4 min; 21 cycles of 94°C for 30 s, 55°C for 30 s,
and 72°C for 30 s; and a final step of 72°C for 8 min.
The primers used for mouse SMS2 RT-PCR were as
follows:
forward: 5’-CAAAACTTGAAGGTCACTTGGA-3’
reverse: 5’-GGTGGGGCTTGTGTAAGTGT-3’
The forward and reverse primer sequences for 18S
rRNA (as an internal control) were 5’-AGTCCCTGC
CCTTTGTACACA-3’ and 5’-GATCCGAGGGCCT-
CACTAAAC-3’, respectively. The PCR products were
visualized by electrophoresis on 1.2% agarose gels, and
the intensity of each band was measured by Image-Pro
Plus version 4.5 software (Media Cybernetics. Inc.).
SMS activity was measured as described previously
[13]. Briefly, the liver was homogenized in a buffer con-
taining 50 mM Tris-HCl, 1 mM EDTA, 5% sucrose, and
protease inhibitors. The homogenate was centrifuged at
5,000 rpm for 10 min, and the supernatant was used to
measure SMS activity. The reaction system contained 10
mM HEPES (pH 7.4), 3 mM MnCl2, C6-nitrobenzoxa-
diazole-ceramide (60 mg/600 ml), and phosphatidylcho-
line (2 mg/600 ml). The mixture was incubated at 37°C
for 2 h. Lipids were extracted in chloroform-methanol
(2:1), dried under N2 gas, and separated by thin layer
chromatography (TLC). The plate was scanned with a
Phosphor imager, and the intensity of each band was
measured by Image-Pro Plus version 4.5 software
(Media Cybernetics, Inc.) [8].
Plasma lipid measurement
Fasting blood was collected. Plasma TC, HDL-C, LDL-C,
and TG levels were determined enzymatically by kits
(Shanghai Rongsheng Biotech Co., Ltd China). Plasma SM
and PC levels were measured as reported previously [8].
Mouse Atherosclerotic Lesion Measurement
The aorta was dissected and the arch photographed, as
previously reported [1]. An aortic lesion en face assay
was performed as previously described [1]. For histo-
morphological analysis, lesional sections were stained
with Oil Red O. We also performed aortic root analysis.
The heart was fixed in 4% formaldehyde and embedded
in paraffin. The aortic root was sectioned into 10 μm-
thick slices and then stained with hematoxylin and
eosin. Six sections from each aortic root, 30 μma p a r t
from each other, were collected. Collagen analysis was
performed with Masson’s trichrome stain. Images were
viewed and captured with a Canon microscope and trea-
ted by Image-Pro Plus 6.0.
Statistical analysis
Differences between groups were tested by Student’s
t-test. Data are presented as means ± SD. P < 0.05 was
considered significant.
Results
To investigate the impact of elevated SMS2 activity on
atherogenesis in vivo, we used AdV-SMS2 to express
human SMS2 in apoE KO mice. AdV-GFP was used as
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diet. On day six after AdV-SMS2 treatment, SMS2
mRNA levels were significantly increased in the liver
(2.7-fold, p < 0.001) compared to AdV-GFP treated
mice (Figure 1). Moreover, AdV-SMS2 administration
caused a 2.3-fold increase (p < 0.001) in liver SMS activ-
ity (Figure 2).
We next measured plasma lipid levels. As indicated in
Additional file 1: Table S1, plasma lipid analysis (AdV-
SMS2 versus AdV-GFP) showed a significant increase of
plasma TC, LDL-C, TG and SM by 39% (p < 0.05), 42%
(p < 0.05), 68% (p < 0.001), and 45% (p < 0.05), respec-
tively and a significant reduction of plasma HDL-C, PC
and PC/SM ratio by 42% (p < 0.05), 18% (p < 0.05), and
45% (p < 0.05), respectively.
To evaluate the impact of SMS2 overexpression on
atherogenesis in apoE KO mice, we dissected the mice
aortas and photographed them on day 30 after AdV-
SMS2 injection. We also measured proximal and whole
aortic lesion areas and found an increase of lesion area
in aortic arches (Figure 3)a n dt h ew h o l ea o r t ac o m -
pared with controls (p < 0.001, Figure 4).
We further investigated the impact of SMS2 overex-
pression on lesion size and collagen content in the aor-
tic root. As shown in Figures 5 and 6, the lesion area in
the aortic root was significantly increased (p < 0.001),
and collage content significantly decreased (p < 0.01)
compared with controls, suggesting that SMS2 overex-
pression not only increases lesion size but also decreases
blood vessel remodeling.
Discussion
In this study, we demonstrated that AdV-mediated
SMS2 overexpression in apoE deficient background
mice caused the following: 1) a significant increase in
h e p a t i cS M S 2m R N Aa n dS M Sa c t i v i t yl e v e l s ;2 )as i g -
nificant increase in plasma SM, TC, TG, and LDL-C
levels and a decrease in plasma HDL-C and PC levels
and in the ratio of PC/SM; and 3) an increase in athero-
sclerotic lesions.
SM is an amphipathic phospholipid located in the sur-
face monolayer of all classes of plasma lipoproteins
(LDL/VLDL, 70-75%; HDL, 25-30%) [14]. Human
plasma SM levels are an independent risk factor for cor-
onary heart disease [11,15]. LDL-SM retained in athero-
sclerotic lesions is hydrolyzed by an arterial wall
sphingomyelinase, which promotes its aggregation by
Figure 1 AdV-SMS2 administration increases liver SMS2 mRNA
levels. Hepatic SMS2 mRNA levels were measured by RT-PCR.
Values shown are mean ± SD, n = 6, **p < 0.001, compared to
AdV-GFP.
Figure 2 AdV-SMS2 administration increases total SMS activity
in the liver. Values shown are mean ± SD, n = 6, **p < 0.001,
compared to AdV-GFP.
Figure 3 AdV-SMS2 administration increases atherosclerotic
lesions in the aortic arch. (Photograph of aortic arch). Panel A.
Control group (AdV-GFP); Panel B. AdV-SMS2 group.
Figure 4 AdV-SMS2 administration increases atherosclerotic
lesions in the entire aorta. (Photograph of the entire aorta
after Oil Red O staining.). Panel A. AdV-GFP group; Panel B. AdV-
SMS2 group. Panel C. Quantification of the lesion areas. Values
shown are mean ± SD (n = 7),** p < 0.001, compared to AdV-GFP.
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cing plasma SM levels could be an effective way to
prevent atherogenesis. It has been reported that a defi-
ciency in SMS2 causes lower plasma SM levels and less
atherogenic lipoprotein aggregation mediated by sphin-
gomyelinase [17]. Our previous study reported that
SM-enriched atherogenic lipoprotein particles from
AdV-SMS2 treated mice or liver-specific SMS2 trans-
genic mice have a stronger potential for aggregation
after sphingomyelinase treatment [8]. The present study
is the first to indicate that elevated SM levels caused by
increased SMS activity promote atherogenesis in a
mouse model.
Collagen is synthesized by vascular smooth muscle cells
and plays an important role during blood vessel remodel-
ing [18]. During atherogenesis, many inflammatory
factors and cytokine are overexpressed, leading to vascu-
lar smooth muscle cell apoptosis and decreased collagen
synthesis. There is a negative relationship between col-
lagen content and atherosclerosis [19]. The present study
shows that SMS overexpression not only increases ather-
osclerotic lesions but also decreases collagen content,
implying a decrease in the ability for blood vessel
remodeling.
The interaction of SM and cholesterol drives the forma-
tion of plasma membrane rafts [20,21]. Adenovirus-
mediated SMS2 expression might alter lipid raft structure,
which is supported by the fact that AdV-mediated SMS1
and SMS2 overexpression can upregulate scavenger recep-
tor B-I (SR-BI) [8], which is closely associated with lipid
rafts on the plasma membrane [21-23]. SR-BI can mediate
the selective uptake of cholesteryl esters from both LDL
Figure 5 AdV-SMS2 administration increases atherosclerotic lesions in the aorta root. (Photograph of the aorta root after H&E
staining.). Panel A. AdV-GFP group. Panel B. AdV-SMS2 group. Panel C. Quantification of the lesion area. Values shown are mean ± SD, n = 5,
**p < 0.001, compared to AdV-GFP.
Figure 6 Collage staining of lesions in the aorta root. Panel A. AdV-GFP group. Panel B. AdV-SMS2 group. Panel C. Quantification of collagen.
Values shown are mean ± SD, n = 5, **p < 0.01, compared to AdV-GFP.
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ently by the integrity of lipid rafts on hepatocyte mem-
branes [24]. This effect could explain why there is a
reduction of HDL-C (Additional file 1: Table S1).
Conclusion
In summary, our results provide the first direct morpho-
logical evidence that SMS2 overexpression can promote
atherosclerosis in a mouse model. Thus, SMS2 could be
a new target for atherosclerosis treatment.
Additional material
Additional file 1: Table S1. Plasma lipid levels in mice overexpressing
SMS2 and in control mice.
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